• Corpus ID: 27631929

NeXstar Pharmaceuticals lauches DaunoXome.

@article{1996NeXstarPL,
  title={NeXstar Pharmaceuticals lauches DaunoXome.},
  author={},
  journal={Journal of the International Association of Physicians in AIDS Care},
  year={1996},
  volume={2 6},
  pages={
          52
        }
}
  • Published 1996
  • Medicine
  • Journal of the International Association of Physicians in AIDS Care
NeXstar Pharmaceuticals has begun marketing DaunoXome (daunorubicin citrate liposome injection), which maximizes the selectivity of daunorubicin for solid tumors. Phase III trials showed the drug to have efficacy comparable to a three-drug regimen of adriamycin, bleomycin, and vincristine (ABV). There was no evidence of cardiotoxicity except at levels greater than six times higher than would normally be tolerated by the patient.